{"latest_checked": "2026-08-03T11:12:42.264912+00:00", "coverage_count": 5079, "recent_count": 8, "transaction_limit": 160, "filters": {"q": "", "ticker": "VRTX", "sector": "", "industry": "", "side": "", "start": "2026-06-19", "end": "2026-08-03"}, "summary": {"total": 8, "acquisition_count": 4, "disposal_count": 4, "acquisition_value": 62499.7953, "acquisition_value_label": "$62.5K", "disposal_value": 2291077.88, "disposal_value_label": "$2.3M", "net_value": -2228578.0847, "net_value_label": "$-2.2M", "flow_tone": "negative", "largest_value_label": "$799.8K", "top_sector": "Healthcare", "window_label": "19 Jun 2026 to 03 Aug 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 8, "value": "2353577.6753", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$2.4M"}], "days": [{"transaction_date": "2026-06-26", "acquisitions": 0, "disposals": 1, "total": 1, "bar_width": 50.0}, {"transaction_date": "2026-07-01", "acquisitions": 0, "disposals": 1, "total": 1, "bar_width": 50.0}, {"transaction_date": "2026-07-02", "acquisitions": 0, "disposals": 2, "total": 2, "bar_width": 100.0}, {"transaction_date": "2026-07-15", "acquisitions": 2, "disposals": 0, "total": 2, "bar_width": 100.0}, {"transaction_date": "2026-07-21", "acquisitions": 2, "disposals": 0, "total": 2, "bar_width": 100.0}], "side_mix": {"acquisitions": 4, "disposals": 4, "acquisition_share": 50.0, "disposal_share": 50.0}}, "company_flows": [{"symbol": "VRTX", "name": "Vertex Pharmaceuticals Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-21", "acquisitions": 4, "disposals": 4, "acquired_value": 62499.7953, "acquired_value_label": "$62.5K", "disposed_value": 2291077.88, "disposed_value_label": "$2.3M", "net_value": -2228578.0847, "net_value_label": "$-2.2M", "acquisition_share": 50.0, "disposal_share": 50.0, "detail_url": "https://sharemaestro.com/insider-activity/company/vrtx/", "research_links": {"chart": "/terminal/85cf1839-5d87-4b1b-8118-600d01682cf0/", "report": "/terminal/85cf1839-5d87-4b1b-8118-600d01682cf0/report/", "factor": "/factors/ticker/85cf1839-5d87-4b1b-8118-600d01682cf0/"}}], "company_overview": [{"symbol": "VRTX", "name": "Vertex Pharmaceuticals Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-21", "filings": 8, "acquisitions": 4, "disposals": 4, "acquired_value": 62499.7953, "acquired_value_label": "$62.5K", "disposed_value": 2291077.88, "disposed_value_label": "$2.3M", "net_value": -2228578.0847, "net_value_label": "$-2.2M", "acquisition_share": 50.0, "disposal_share": 50.0, "tone": "Mixed flow", "tone_class": "neutral", "detail_url": "https://sharemaestro.com/insider-activity/company/vrtx/", "research_links": {"chart": "/terminal/85cf1839-5d87-4b1b-8118-600d01682cf0/", "report": "/terminal/85cf1839-5d87-4b1b-8118-600d01682cf0/report/", "factor": "/factors/ticker/85cf1839-5d87-4b1b-8118-600d01682cf0/"}}], "transactions": [{"symbol": "VRTX", "name": "Vertex Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-21", "executive": "SACHDEV, AMIT", "executive_title": "EVP Chief Patient & Ext Af Off", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 8251.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T10:47:04.863424+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/vrtx/", "research_links": {"chart": "/terminal/85cf1839-5d87-4b1b-8118-600d01682cf0/", "report": "/terminal/85cf1839-5d87-4b1b-8118-600d01682cf0/report/", "factor": "/factors/ticker/85cf1839-5d87-4b1b-8118-600d01682cf0/"}}, {"symbol": "VRTX", "name": "Vertex Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-21", "executive": "TATSIS, OURANIA", "executive_title": "EVP, Chief Reg. & Quality Off.", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 8251.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T10:47:04.871867+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/vrtx/", "research_links": {"chart": "/terminal/85cf1839-5d87-4b1b-8118-600d01682cf0/", "report": "/terminal/85cf1839-5d87-4b1b-8118-600d01682cf0/report/", "factor": "/factors/ticker/85cf1839-5d87-4b1b-8118-600d01682cf0/"}}, {"symbol": "VRTX", "name": "Vertex Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "SACHS, BRUCE I", "executive_title": "Director", "security_type": "Deferred Stock Units", "side_code": "A", "side": "Acquisition", "shares": 99.941, "share_price": 475.28, "transaction_value": 47499.9585, "fetched_at": "2026-07-31T10:47:04.874411+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/vrtx/", "research_links": {"chart": "/terminal/85cf1839-5d87-4b1b-8118-600d01682cf0/", "report": "/terminal/85cf1839-5d87-4b1b-8118-600d01682cf0/report/", "factor": "/factors/ticker/85cf1839-5d87-4b1b-8118-600d01682cf0/"}}, {"symbol": "VRTX", "name": "Vertex Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "GARBER, ALAN M", "executive_title": "Director", "security_type": "Deferred Stock Units", "side_code": "A", "side": "Acquisition", "shares": 31.56, "share_price": 475.28, "transaction_value": 14999.8368, "fetched_at": "2026-07-31T10:47:04.876674+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/vrtx/", "research_links": {"chart": "/terminal/85cf1839-5d87-4b1b-8118-600d01682cf0/", "report": "/terminal/85cf1839-5d87-4b1b-8118-600d01682cf0/report/", "factor": "/factors/ticker/85cf1839-5d87-4b1b-8118-600d01682cf0/"}}, {"symbol": "VRTX", "name": "Vertex Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-02", "executive": "MCKECHNIE, DUNCAN", "executive_title": "EVP, Chief Commercial Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 1541.0, "share_price": 519.0, "transaction_value": 799779.0, "fetched_at": "2026-07-23T22:09:01.445727+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/vrtx/", "research_links": {"chart": "/terminal/85cf1839-5d87-4b1b-8118-600d01682cf0/", "report": "/terminal/85cf1839-5d87-4b1b-8118-600d01682cf0/report/", "factor": "/factors/ticker/85cf1839-5d87-4b1b-8118-600d01682cf0/"}}, {"symbol": "VRTX", "name": "Vertex Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-02", "executive": "TATSIS, OURANIA", "executive_title": "EVP, Chief Reg. & Quality Off.", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 1500.0, "share_price": 524.99, "transaction_value": 787485.0, "fetched_at": "2026-07-23T22:09:01.447379+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/vrtx/", "research_links": {"chart": "/terminal/85cf1839-5d87-4b1b-8118-600d01682cf0/", "report": "/terminal/85cf1839-5d87-4b1b-8118-600d01682cf0/report/", "factor": "/factors/ticker/85cf1839-5d87-4b1b-8118-600d01682cf0/"}}, {"symbol": "VRTX", "name": "Vertex Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "LIU, JOY", "executive_title": "EVP and Chief Legal Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 828.0, "share_price": 502.71, "transaction_value": 416243.88, "fetched_at": "2026-07-22T10:59:10.304522+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/vrtx/", "research_links": {"chart": "/terminal/85cf1839-5d87-4b1b-8118-600d01682cf0/", "report": "/terminal/85cf1839-5d87-4b1b-8118-600d01682cf0/report/", "factor": "/factors/ticker/85cf1839-5d87-4b1b-8118-600d01682cf0/"}}, {"symbol": "VRTX", "name": "Vertex Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "BOZIC, CARMEN", "executive_title": "EVP and CMO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 596.0, "share_price": 482.5, "transaction_value": 287570.0, "fetched_at": "2026-07-16T22:04:37.230763+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/vrtx/", "research_links": {"chart": "/terminal/85cf1839-5d87-4b1b-8118-600d01682cf0/", "report": "/terminal/85cf1839-5d87-4b1b-8118-600d01682cf0/report/", "factor": "/factors/ticker/85cf1839-5d87-4b1b-8118-600d01682cf0/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}